Aeona Pharmaceuticals
Aeona Pharmaceuticals offers AI-powered antibody discovery and engineering to accelerate biopharma drug development. It uses an AI-driven platform to design and optimize antibodies, enabling in silico screening of up to 10^25 variants. The approach combines humanized antibody discovery with rational data-driven engineering to improve properties before lab testing. The company targets biopharma clients seeking faster, data-backed therapeutic candidates through in-house AI tools. With a focus on scalable biologics, Aeona aims to broaden access to novel antibody therapeutics.
Aeona Pharmaceuticals
Aeona Pharmaceuticals offers AI-powered antibody discovery and engineering to accelerate biopharma drug development. It uses an AI-driven platform to design and optimize antibodies, enabling in silico screening of up to 10^25 variants. The approach combines humanized antibody discovery with rational data-driven engineering to improve properties before lab testing. The company targets biopharma clients seeking faster, data-backed therapeutic candidates through in-house AI tools. With a focus on scalable biologics, Aeona aims to broaden access to novel antibody therapeutics.